Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2020 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
OM on Nasdaq
Shares outstanding
17,721,988
Price per share
$14.12
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
176,842
Total reported value
$2,498,949
% of total 13F portfolios
0%
Share change
+142,108
Value change
+$2,006,565
Number of holders
3
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Durable Capital Partners LP 9.9% $14,967,619 26,609,101 Durable Capital Partners LP 03 Jan 2025
PFM Health Sciences, LP 9.4% $14,062,500 25,000,000 PFM Health Sciences, LP 10 Mar 2025
PERCEPTIVE ADVISORS LLC 9.5% $3,164,062 5,625,000 Perceptive Advisors LLC 08 Jan 2025
FMR LLC 7% $2,065,057 3,671,213 FMR LLC 31 Dec 2024
VANGUARD GROUP INC 5% $1,467,507 2,608,902 The Vanguard Group 31 Dec 2024
Alyeska Investment Group, L.P. 9.6% $957,984 1,703,083 Alyeska Investment Group, L.P. 31 Mar 2025

As of 30 Sep 2025, 3 institutional investors reported holding 176,842 shares of Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM). This represents 1% of the company’s total 17,721,988 outstanding shares.

Institutional Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 176,842 $2,498,949 +$2,006,565 $14.12 3
2025 Q2 34,734 $667,997 +$195,729 $21.73 2
2025 Q1 24,600 $271,908 -$26,758,577 $5.81 2
2024 Q4 21,051,631 $23,361,421 -$3,640,990 $1.11 73
2024 Q3 26,056,953 $17,615,217 -$39,744,151 $0.68 76
2024 Q2 48,587,472 $187,046,738 -$3,405,355 $3.85 118
2024 Q1 49,978,472 $110,947,103 -$22,701,144 $2.22 108
2023 Q4 20,127 $108,887 -$290,387 $5.41 1
2023 Q3 52,696,584 $573,286,404 -$1,991,091 $10.88 148
2023 Q2 52,027,529 $1,137,243,649 +$26,201,850 $21.87 151
2023 Q1 51,055,758 $939,264,233 +$47,748,711 $18.40 157
2022 Q4 48,985,134 $1,264,887,705 +$454,258 $25.82 145
2022 Q3 47,263,108 $751,942,993 -$60,234,217 $15.93 126
2022 Q2 48,461,305 $719,545,889 -$164,438,232 $14.86 141
2022 Q1 51,294,792 $2,328,266,118 +$123,288,361 $45.40 146
2021 Q4 45,498,171 $2,096,853,401 -$211,104,400 $46.09 152
2021 Q3 50,674,901 $2,506,125,357 +$213,157,487 $49.44 138
2021 Q2 46,254,297 $2,311,097,576 +$390,178,877 $49.98 126
2021 Q1 38,393,386 $2,088,213,344 +$50,140,415 $54.39 109
2020 Q4 37,414,643 $2,088,174,575 +$69,476,200 $56.84 108
2020 Q3 35,922,924 $1,749,967,350 +$1,749,967,807 $50.00 82